Illumina, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (54)

Latest Posts

About This Stock More About This Stock
After-Hours Movers; DocuSign Crashes Over 20%
Article By: The Fly
Friday, June 10, 2022 4:18 AM EDT
DocuSign crashes over 20% after Q1 earnings miss; Illumina slips 6% as company CFO steps down, and more from after hours.
In this article: MTNOY, ANGI, ILMN, RENT, CMTL, SFIX, DOCU
Read
Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers
Article By: Benzinga
Saturday, April 16, 2022 2:26 PM EDT
Let’s pause to consider earlier attempts at hostile takeovers by well-respected and well-financed entities and individuals that — to ransack some Musk-worthy clichés — took off like a rocket ship but eventually vanished like a wisp of blunt smoke.
In this article: XRX, ILMN, NFLX, PACB, RHHBY, MSFT, HPQ, TSLA, TWTR Also: VZ, NWS, IBM
Read
Illumina Jumps As Gene Sequencing Demand Drives Stronger Outlook
Article By: The Fly
Tuesday, January 11, 2022 2:36 PM EDT
Piper says Pacific Bio has a new competitor in Illumina amid plans to launch what looks like a consumable allowing long-read sequencing on its analyzers.
In this article: ILMN Also: UNH, PACB
Read
Illumina Slides After 'Confusing' Close Of Grail Deal Amid Antitrust Probe
Article By: The Fly
Thursday, August 19, 2021 1:10 PM EDT
Citi sees some risk that Illumina's tactic does not sit well with the regulatory bodies.
In this article: ILMN
Read
3 Large-Cap Growth Stocks To Add To Your Portfolio This Summer
Article By: StockNews
Friday, July 9, 2021 9:26 AM EDT
Even though investors rotated away from expensive growth stocks earlier this year, select growth stocks have been experiencing strong rebounds and in some instances are making new highs.
In this article: ILMN, ISRG, EW Also: SPYG
Read

Latest Tweets for $ILMN

No tweets yet!

PARTNER HEADLINES

$ILMN

Illumina: A Growth Leader In The Genomic Revolution
Mitch Reynolds 6/25/2020 4:46:47 PM

You make some good points. I've reconsidered buying $ILMN.

1 to 1 of 1 comments